Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

CTSOCTSO
Showing 8 of 31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in CYTOSORBENTS CORP

GEODE CAPITAL MANAGEMENT, LLC holds 602,059 shares of CTSO (CYTOSORBENTS CORP), worth $225,239 as of 2026-Q2. The position was decreased (-14.9% shares).

Current Value

$225,239

Current Shares

602,059

Total Value Change

-$475,492

Total Shares Change

+135,001

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
602,059
-14.9%
$225,2390.0%$0.37
0
2026-Q1
Increased
707,262
+17.1%
$400,6210.0%$0.80
19
2025-Q4
Increased
603,767
+0.4%
$386,0340.0%$0.64
16
2025-Q3
Unchanged
601,451
0.0%
$561,9780.0%$0.93
0
2025-Q2
Decreased
601,451
-2.0%
$770,0630.0%$1.23
0
2025-Q1
Increased
613,855
+29.5%
$614,0510.0%$1.00
21
2024-Q4
Increased
474,153
+1.5%
$431,5880.0%$0.90
17
2024-Q3
Increased
467,058
+7.5%
$700,7310.0%$1.50
26

Other major holders of CTSO: BNP PARIBAS FINANCIAL MARKETS, Neuberger Berman Group LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used